Synchron Companies

Synchron is a neurotechnology company based in New York that develops implantable brain-computer interface (BCI) devices. These devices aim to address neurological limitations and enhance autonomy for individuals with conditions such as paralysis and ALS. The company focuses on minimally invasive neurotechnology, utilizing intravascular implantation methods to avoid the risks associated with open-brain surgery.

Synchron's BCI technology enables users to perform everyday digital interactions, such as scheduling medical appointments and messaging, through direct brain signal interpretation. The company serves healthcare institutions, research organizations, and medical facilities, providing advanced solutions in the neuroprosthetics market. With a dedicated team of 51-200 employees and an estimated annual revenue of $10M-$50M, Synchron is positioned as a stable player in the medical equipment manufacturing sector, emphasizing patient autonomy and seamless integration with digital ecosystems.

Investors

Technology: ['BioTech & HealthTech']
Last Funding Type: Series C
Founded Date: 2016
Investment Stage: N/A
Total Funding: 130000000.0
Investor Type: Company
Funding Status: Late Stage Venture
Employee Number: 130
Industry: medical devices
Headquarters: 63 Flushing Ave, New York, New York, United States, 11205
Number Of Exists: Series A
Investors Number: 23.0
Estimated Revenue: $50M to $100M
Last Funding Date: 2022-12-15
Register and Claim Ownership